drugset / Trial / NCT04141150
Evaluation of [18F]APN-1607 PET Uptake in Alzheimer's Disease Patients Compared With Healthy Subjects
NaSingle-groupOpen-labelOther
Summary
The overall objective of this study is to compare the overall pattern of \[18F\]APN-1607 uptake in subjects with MDAD, subjects with AD dementia, and healthy subjects.
Timeline
- Start
- 2022-03-22
- Primary completion
- 2024-09
- Completion
- 2025-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | [18F]APN-1607 | Diagnostic / imaging agent | 259 mbq | Intravenous |